Providence Holy Cross Health Hour – antibodies and their importance

Share this Article
Facebook
Twitter
LinkedIn

Tom Burton, PT, talks about the latest updates and changes in the Safer At Home orders that are in place in the Santa Clarita Valley and provides advice on how to keep yourself protected from getting or spreading Covid-19. Dr. Bernard Fox also joins the show to talk about looking into different people who have been able to resist contracting Covid-19. Dr. Fox has been doing research and testing on the blood, and antibodies found in the blood, that contribute to the person’s ability to fight off Covid-19.

Listen in to a fascinating show as Tom Burton talks to Dr. Bernard Fox about the antibodies in individuals who have recovered from or resisted Covid-19.

About the Author

The Providence News Team brings you the updates to keep you informed about what's happening across the organizational ecosystem. From partnerships to new doctor announcements, we are committed to keeping you informed.
More Content by Providence News Team

We are COVID Strong

Leaders from around the country came together to bring a few words of encouragement during these difficult ...

As pandemic spreads, use of telehealth by clinicians and health systems surges

Dr. Gregg VandeKieft, palliative care specialist, began seeing clients through televisits for the first tim...

Other content in this Stream

Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

Providence Holy Cross Health Hour – antibodies and their importance

About the Author

Previous Article

Next Article

Other content in this Stream

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

Providence and Compassus have announced an agreement to form a joint venture partnership for home health, hospice, community-based palliative care, and private duty caregiving services.

Baylor Scott & White Health, Memorial Hermann Health System, Novant Health and Providence have announced the formation of Longitude Health.

Year-long study, published in Health Affairs Scholar, prompts need for multi-level intervention to increase adoption rates, combat cancer inequities

A study released today indicates that burden of quality measures may be counterproductive in patient care, suggests possible need for intervention

Data published in the New England Journal of Medicine Catalyst reported that MedPearl, a Providence-developed platform, improves primary care clinician productivity, decreases time waste.

Providence announced results for the three months ended June 30, 2024, which showed continued improvement in operating performance.

A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.

The Providence St. Joseph Health Board of Directors announced that Providence Chief Operating Officer Erik Wexler has been named the health system’s next president and chief executive officer.

Supporting people in times of need, remote capabilities have enabled Providence chaplains to care for over 1,000 people since 2022.

Over the next three years, this study seeks to identify the patterns of access and use of cancer services among high-risk patients to understand how to guide them toward quality care.

Investments focus on addressing social determinants of health and ensuring continued access to vital care for those in need

Network members focus on helping caregivers address community health needs through service, advocacy, and giving.

CHA has named Providence Chief Communication Officer Orest Holubec as vice chairperson/chairperson-elect of the CHA Board of Trustees, while Chief Legal Officer Anna Newsom was elected to the Board.

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.

The 2023 Providence Research Network annual report, released on Clinical Trials Day 2024, highlights the breadth and impact of research at Providence.

With a continued focus on strategies for recovery and renewal, Providence reported a positive first quarter.

After 45 years in health care, including 17 with the Providence family of organizations, Rod Hochman, M.D., announced that he will retire as president and CEO of Providence at the end of 2024.

Providence has been presented with 55 Practice Greenhealth Environmental Excellent Awards in recognition of exceptional environmental stewardship across the organization.